Methods for assessing transendothelial barrier integrity

An integrity and endothelial technology, applied in vascular endothelial cells, biochemical equipment and methods, pharmaceutical formulations, etc., can solve problems such as difficult to apply drug exploration, difficult to accurately reproduce, and very complex.

Pending Publication Date: 2021-03-26
F HOFFMANN LA ROCHE & CO AG
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The main disadvantage of these published models is that they are very complex and difficult to reproduce accurately, making them difficult to apply to drug discovery

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for assessing transendothelial barrier integrity
  • Methods for assessing transendothelial barrier integrity
  • Methods for assessing transendothelial barrier integrity

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0181] Genome editing of the CLDN5 transcriptional reporter gene in hPSCs.

[0182] To assess the barrier properties of endothelial cells with surrogate markers, CLDN5 was tagged with a P2A self-cleaving peptide and GFP at the 3' end ( Figure 1a ). We designed sgRNA near the stop codon of CLDN5 and simultaneously generated a donor plasmid ( Figure 1b ) to carry a promoterless P2A-GFP sequence flanked by two homology arms (HA) with piggyBac inverted terminal repeats at each end allowing scarless excision of the resistance gene cassette sequence (ITR). Double-strand breaks caused by Cas9 and sgRNA are repaired by homologous recombination between CLDN5 and the donor template ( Figure 1c ), followed by removal of the resistance gene cassette by piggybac transposase only for excision ( Figure 1d ). Single cell clones are picked and expanded. We assessed tTK deficiency by qPCR (not shown) and identified several tTK-deficient clones. Correct GFP insertion and orientation of...

example 2

[0184] Generation and characterization of a CLDN5 reporter gene in stem cell-derived endothelial cells. Human The pluripotent stem cell line reporter line and WT line differentiated into endothelial cells and 15% to 25% GFP+ cells ( Figure 2b , depending on the clone, data for one clone are shown), no GFP+ cells were observed in the WT line. GFP+ and GFP- cells were sorted by FACS, and electronic cell-matrix impedance was judged. A 1.75-fold increase in barrier impedance was observed in GFP+ cells (3200 Ω, Figure 2c ). Next, RNA-sequencing and TMT large-scale proteomic studies were performed on both FACS-sorted GFP+ and GFP- cells (not shown), and very good correlations between significantly altered proteins and corresponding mRNAs were observed. Correlation (r=0.79, p Figure 2d ). Significant upregulation of CLDN5 at the mRNA and protein levels was confirmed ( Figure 2e ), but also confirmed significant upregulation of other tight junction proteins (OCLN) and MARVELD...

example 3

[0186] CLDN5-GFP+ EC display a high functional response across the endothelial barrier integrity. Next, gene set enrichment analysis was performed (GSEA, Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al., Proceedings of the National Academy of Sciences of the United States of America. 2005; 102( 43):15545-50.), using Hallmarks MsigDB (Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. Cell systems. 2015; 1(6):417-25.) database and using Ranked lists of the products of log2FC and -log10FDR of selected GFP+ cells compared to GFP- cells (data not shown) were used for this analysis. Interestingly, enrichment of angiogenesis, TGFβ, and E2F proliferation pathways was found among downregulated genes, whereas enrichment of WNT signaling was found among upregulated genes (data not shown). Pathway enrichment analysis (Zhou Y, Wang Y, Tischfield M, Williams J, Smallwood PM, Rattner A, et al., The Journal of clinical investigation. 2014;...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to view more

Abstract

This application relates to a method for identifying a drug candidate capable of increasing or decreasing barrier tissue integrity of endothelial cells. Moreover, this application relates to the use of a tight junction gene transcriptional reporter as a surrogate marker of transendothelial barrier integrity.

Description

technical field [0001] The present application relates to a method for identifying drug candidates capable of increasing or decreasing the barrier integrity of endothelial cells. Furthermore, the present application relates to the use of tight junction gene transcriptional reporters as surrogate markers of transendothelial barrier integrity. Background technique [0002] The endothelial cell barrier forming the blood-retinal barrier (BRB) and blood-brain barrier (BBB) ​​is critical for homeostasis and protection against toxicity and infection to the eye and brain (Engelhardt B, Liebner S. Cell and tissue research. 2014; 355( 3):687-99, Diaz-Coranguez M, Ramos C, Antonetti DA. Visionresearch. 2017; 139:123-37). Disruption of the endothelial barrier is associated with various retinal diseases, such as familial exudative vitreoretinopathy (Gilmour DF. Eye (London, England). 2015; 29(1):1-14), age-related macular degeneration and Diabetic retinopathy (Klaassen I, Van Noorden C...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/071G01N33/50A61K38/18A61K31/536
CPCG01N33/5023G01N33/5032G01N33/5064G01N33/5073C12N5/069C12N2501/15C12N2501/727C12N2503/02C12N2506/03C12N2510/00A61K31/4745A61K38/00A61K31/4439C12Q1/6897
Inventor C·A·考恩C·A·迈尔F·鲁德尼基张继涛
Owner F HOFFMANN LA ROCHE & CO AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products